Bill Interviews with ACS Infectious Diseases for an Editorial!

Bill was recently interviewed for an American Chemical Society Infectious Diseases Editorial!

The editorial honors Bill's research contributions to the field of infectious diseases for their innovation and significant impact, particularly in developing therapeutic strategies against challenging microbial pathogens. The article focuses on Bill's pioneering approach to de novo protein design, which has profound implications for creating treatments targeting infectious agents such as the development of Brilacidin, a drug candidate classified as a defensin-mimetic that is one of Bill's most notable achievements.

Bill is also recognized beyond his technological and research contributions as an inspirational mentor in the scientific community. His dedication to nurturing future generations of scientists is evident through his mentorship of over 50 Ph.D. students and postdoctoral fellows, many of whom have gone on to distinguished careers in academia and industry. This legacy highlights the lasting impact of his mentorship and influence on the scientific community.

https://pubs.acs.org/doi/epdf/10.1021/acsinfecdis.5c00396?ref=article_openPDF